Therapeutics immunotargets for Tauopathy
Advances in Protein Chemistry and Structural Biology · 2025
DOI: 10.1016/bs.apcsb.2025.10.015 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Protein Chemistry and Structural Biology, 2025. Verfasst von Subashchandrabose Chinnathambi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences Hospital (NIMHANS), Institute of National Importance, Bangalore,…. Hauptthemen laut MEDLINE: Tauopathies, tau Proteins, Alzheimer Disease. Die Arbeit nennt 247 Literaturangaben. Gefördert von: National Institute of Mental Health and Neurosciences.
Abstract (Originalsprache)
Alzheimer's disease is a multi-factor involved neurodegenerative disease. In Alzheimer's condition, the pathological protein transfer from cell to cell and cause other cells to degenerate, similar to prion like diseases, this pathological protein transfer is exacerbated by neuroinflammation, mitochondrial dysfunction, oxidative stress, autophagy impairment, and cholinergic deficits. Neuroinflammation, driven by chronic microglial activation, produces excessive cytokines that worsen Tau hyperphosphorylation. Mitochondrial dysfunction, characterized by impaired energy metabolism, enzyme deficits in the TCA cycle, and ROS overproduction, leads to oxidative damage to proteins, lipids, and nucleic acids. Oxidative stress further accelerates neuronal damage. Autophagy dysfunction, caused by impaired mTOR signalling, disrupts the clearance of Aβ and Tau, facilitating their accumulation. Additionally, cholinergic deficits, including reduced acetylcholine levels, impair cognitive functions like memory and learning. Therapeutic approaches targeting these interconnected mechanisms, such as modulating inflammation, restoring mitochondrial and autophagy functions, and addressing the amyloid and Tau pathways will offers promising directions for treating Alzheimer's disease by developing an effective intervention to manage this debilitating disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences Hospital (NIMHANS), Institute of National Importance, Bangalore, Karnataka, India. Electronic address: subashneuro@nimhans.ac.in.
- Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences Hospital (NIMHANS), Institute of National Importance, Bangalore, Karnataka, India.
Förderung
- National Institute of Mental Health and Neurosciences
Zitieren
APA
Chinnathambi, S., & Rangappa, N. (2025). Therapeutics immunotargets for Tauopathy. Advances in Protein Chemistry and Structural Biology. https://doi.org/10.1016/bs.apcsb.2025.10.015
Vancouver
Chinnathambi S, Rangappa N. Therapeutics immunotargets for Tauopathy. Advances in Protein Chemistry and Structural Biology. 2025. doi:10.1016/bs.apcsb.2025.10.015
BibTeX
@article{Chinnathambi2025,
author = {Chinnathambi, Subashchandrabose and Rangappa, Nagaraj},
title = {Therapeutics immunotargets for Tauopathy},
journal = {Advances in Protein Chemistry and Structural Biology},
year = {2025},
doi = {10.1016/bs.apcsb.2025.10.015}
}
EUVIMED